Market Tracker

04/28 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

5.55
Delayed Data
As of Apr 28
 -0.10 / -1.77%
Today’s Change
3.20
Today|||52-Week Range
18.36
+40.51%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close5.65
Today’s open5.70
Day’s range5.45 - 5.70
Volume617,313
Average volume (3 months)1,290,097
Market cap$261.3M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+29.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
MTNBMatinas BioPharma Ho...-0.11-3.87%
ZGNXZogenix Inc0.000.00%
ZYNEZynerba Pharmaceutic...-0.01-0.05%
NERVMinerva Neuroscience...-0.10-1.30%
Data as of 4:01pm ET, 04/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts